Therefore, these compounds are considered as potent apoptosis-promoting agents. The predicted docking studies and in silico chemo-informatic properties of compounds 7a and 8e were appropriate. Compounds 7a and 8e are promising anti-breast cancer agents exhibiting potent apoptosis-promoting properties.Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD); no approved therapies for NASH currently exist. Pegbelfermin (PGBF), a human fibroblast growth factor 21 analog, has metabolic effects that may provide benefit for patients with NASH.
The FALCON 1 and 2 studies are phase 2b, multicenter, double-blind, placebo-controlled, randomized trials to assess safety and efficacy of PGBF treatment in patients who have histologically-confirmed NASH with stage 3 liver fibrosis (FALCON 1; NCT03486899) or compensated cirrhosis (FALCON 2; NCT03486912). In both studies, randomized patients receive once weekly subcutaneous injections of PGBF (10, 20, or 40mg) or placebo during a 48-week treatment period and are then followed for an additional 4weeks.
The primary efficacy endpoint for FALCON 1 is the proportion of patients who achieve ?1 stage improvement in fibrosis (by NASH CRN fibrosis score) without NASH worsening or NASH improvement (?2 point decrease in NAFLD Activity Score) without fibrosis worsening at Week 24. For FALCON 2, the primary efficacy endpoint is ?1 stage improvement in fibrosis without NASH worsening at Week 48. Key safety endpoints for both studies include incidence and frequency of adverse events, bone mineral density and immunogenicity.
Previous clinical trial data show that PGBF can reduce hepatic fat and improve metabolic factors and biomarkers of hepatic injury and fibrosis. The FALCON studies aim to evaluate PGBF treatment specifically in patients with NASH and advanced fibrosis, who are at greatest risk of poor clinical outcomes over time.
Previous clinical trial data show that PGBF can reduce hepatic fat and improve metabolic factors and biomarkers of hepatic injury and fibrosis. The FALCON studies aim to evaluate PGBF treatment specifically in patients with NASH and advanced fibrosis, who are at greatest risk of poor clinical outcomes over time.Acute alcohol consumption has been shown to increase food intake, and long-term alcohol consumption may be a risk for weight gain. A potential, but under-studied, mechanism for this effect is alcohol's ability to enhance food reward. In two studies, participants consumed an alcoholic drink (Study 1 0.3 grams of alcohol per kilogram of bodyweight (g/kg); Study 2 0.6 g/kg) and a placebo-alcohol drink in a within-subjects design. In both studies, food-related appetitive and motivational states, and attentional bias (AB) towards food-related cues were measured. In Study 1 (N = 44), participants completed a visual probe task with concurrent recording of eye-movements which measured AB towards images of palatable foods, unpalatable foods, and non-food control items. https://www.selleckchem.com/peptide/adh-1.html Participants also completed measures of appetite and snack urge ratings, salivary response towards palatable foods and an ad libitum food taste test. In Study 2 (N = 84), participants completed a similar procedure, but completed a modified Stroop task which measured differences in food-related and alcohol-related AB across the two drink conditions. In Study 1, there was no difference in food-related AB between drink conditions, and no differences in snack urge, appetite ratings, salivary response, or food intake. In contrast, Study 2 showed an alcohol-induced increase in AB towards food, but not alcohol. Snack urge, alcohol urge ratings and ad libitum food intake were also higher after alcohol consumption, relative to the placebo. Collectively, these findings suggest that alcohol can increase food reward and food intake, but these effects may only occur at a higher dose.Previously, we demonstrated that, in the short term, infants undercompensated for the energy from a preload given 25 min before an ad libitum meal. However, although not consistent, there is evidence in young children that caloric adjustment may occur over longer periods. We investigated the extent to which further energy adjustment occurs up to 24 h after a single meal preceded by preloads of varying energy density (ED) in infants that are 11 and 15 months old. Short-term caloric adjustment was measured in 11- and 15-month-old infants through a preload paradigm meal in the laboratory. To assess their caloric adjustment over longer periods (12 and 24 h), we used 24 h dietary records to evaluate the energy intake (EI) after each visit to the laboratory. Three COMPX scores were calculated according to three different time periods after preload consumption (0 h [i.e., short-term], 12 h or 24 h). Our main result was that, on average, regardless of the time period considered, the infants undercompensated their EI after preload consumption at 11 and 15 months, caloric adjustment was partial and similar overtime. Considering that a slight repeated imbalance of the energy balance may promote rapid weight gain over the first months, this study calls for further research focusing on facilitators and barriers of efficient appetite control abilities in infancy.Nostalgia is a prominently used emotion in marketing. This work adds to the burgeoning literature on how feelings of nostalgia influence consumption behavior by investigating how nostalgia influences eating attitudes and behaviors. Two experiments showed that people consumed more and reported more favorable attitudes towards healthy food when feeling nostalgic (versus neutral). Nostalgia also diminished the consumption of unhealthy food. Process evidence revealed that nostalgia's differential influence on the consumption of healthy and unhealthy foods is due to increased perceptions of social support. Since perceptions of social support increase self-control resources, individuals were better able to make healthier food choices when in a nostalgic (versus neutral) state. The findings provided behavioral evidence that nostalgia positively influences healthy eating attitudes and behavior, and established perceived social support as an important mechanism underlying these effects. This work suggests that nostalgia can be a useful tool not only in our commercial marketing efforts, but also in public policy, in that it can help promote healthy food intake and well-being.